PHAXIAM Therapeutics Competitors and Similar CompaniesClear all

PHAXIAM Therapeutics's competitors and similar companies include Polymun, Aeglea and Genentech.

	PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors.	Polymun Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners.	Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 2004	Founding Date 1992	Founding Date 2013	Founding Date 1976
Type	Type Public	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech contractor drug development pharma	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Lyon, FR HQ Cambridge, US Princeton, US	Locations Klosterneuburg, AT HQ	Locations Austin, US HQ	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 49	Employees 80	Employees 65117% increase	Employees 18,077
Valuation ($)	Valuation ($) 52.8 m	Valuation ($) N/A	Valuation ($) 48.6 m	Valuation ($) N/A
Financial
Net income	Net income (€23.5m) (FY, 2023)	Net income N/A	Net income ($155.2m) (FY, 2025)	Net income N/A